IGF1 and hypopituitarism: In clinical practice, before the treatment choice, we suspect difficult/aggressive GH-secreting adenomas/PitNET typically in cases of young patients, who might also refer signs and symptoms of hypopituitarism rather than those related to GH/IGF-I excess.